Premier issues nuclear group buy
ADAC Laboratories of Milpitas, CA, and Siemens Medical Systems of Hoffman Estates, IL, have been named the preferred vendors in a dual-source group buy of nuclear medicine equipment issued by group purchasing organization Premier. Premier members are
ADAC Laboratories of Milpitas, CA, and Siemens Medical Systems of Hoffman Estates, IL, have been named the preferred vendors in a dual-source group buy of nuclear medicine equipment issued by group purchasing organization Premier. Premier members are expected to purchase at least $20 million in equipment from the two companies, according to Pam Parker, director of group buys at the San Diego-based GPO.
Premier selected ADAC and Siemens after surveys of Premier members indicated that the two companies were the highest favored gamma camera vendors, Parker said. Premier members have until mid-May to issue purchase orders that will allow them to lock in the pricing discounts reached under agreement with ADAC and Siemens. Some 62 Premier hospitals have indicated that they are interested in participating in the group buy.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
